Bill Would Bar 340B Upfront Payment Rebates
Reps. Jack Bergman and Raul Ruiz introduce legislation protecting a broader group of safety-net providers from rebate arrangements.
Updated on Nov. 11, 2026 in Healthcare

Live Poll
Should Congress shield rural hospitals and health centers from upfront drug-price rebate rules?
Reps. Jack Bergman and Raul Ruiz introduced the Safety Net Provider Drug Pricing Protection Act, H.R. 10919, on October 29. The bill would prohibit 340B arrangements requiring critical access hospitals, federally qualified health centers and sole community hospitals to pay above the ceiling price upfront and recover the difference through a rebate.
Why it matters
The release states the rebate model would force providers to buy drugs at full price and wait for reimbursement, creating financial and administrative burdens for smaller providers with limited reserves. The bill extends protection beyond H.R. 7391, which covers only federally qualified health centers.
HRSA has approved 10 drugmakers to participate in the 340B rebate pilot, and a separate House bill would delay the pilot by two years. The Safety Net Provider Drug Pricing Protection Act would extend its protections to critical access hospitals, federally qualified health centers and sole community hospitals.
The players
Jack Bergman
Republican U.S. Representative from Michigan who co-sponsored the Safety Net Provider Drug Pricing Protection Act.
Raul Ruiz
Democratic U.S. Representative from California who co-sponsored the Safety Net Provider Drug Pricing Protection Act.
National Association of Community Health Centers
National trade group representing federally qualified health centers that supports the bill.
The details
The bill would bar 340B arrangements that require upfront payment above the ceiling price followed by recovery through a rebate, reimbursement or other payment. Supporters include Aspirus Health, OSF St. Francis Hospital, Schoolcraft Memorial Hospital, Kalkaska Memorial Health Center, Munising Memorial Hospital, Helen Newberry Joy Hospital, Mackinac Straits Hospital, the Michigan Center for Rural Health and the National Association of Community Health Centers.
Timeline
October 29, 2026: Bergman and Ruiz introduce H.R. 10919.
November 11, 2026: Congressional office release announces the bill.
Legislative Context
The bill builds on H.R. 7391, the Community Health Center Drug Pricing Protection Act, which protects only federally qualified health centers. It extends that approach to critical access hospitals and sole community hospitals as HRSA's 340B rebate pilot, with ten approved drugmakers, faces lawsuits and a competing House proposal to delay it.
If enacted, the bill would shield critical access hospitals, federally qualified health centers and sole community hospitals from paying full price upfront for 340B drugs. The protection would ease cash-flow pressure on smaller providers that rely on reimbursement for their drug supply.
The takeaway
Watch whether H.R. 10919 advances alongside the rebate pilot litigation and the competing proposal to delay it, since those outcomes will determine how safety-net providers buy 340B drugs. Providers with limited cash reserves should track the bill's progress closely.
Further reading
For more on the broader policy fight, see Healthcare coverage across the United States.
Source note: This article includes information reported by Becker's Hospital Review | Healthcare News & Analysis.
Live Poll
Should Congress shield rural hospitals and health centers from upfront drug-price rebate rules?






